Covered recipient · General Payments record
KHAWAR A CHAUDHRY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,265.01
- Reported across 112 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $348.82 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $116.75 | 5 |
| USWM, LLC | $49.95 | 3 |
| Neurocrine BioSciences, Inc. | $38.43 | 2 |
| Lilly USA, LLC | $36.21 | 2 |
| Orexo US, Inc. | $34.78 | 2 |
| Indivior Inc. | $33.44 | 2 |
| Braeburn Inc. | $23.20 | 1 |
| Ardelyx, Inc. | $16.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ardelyx, Inc. | $16.06 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146674848 | CMS |
| Braeburn Inc. | $23.20 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125604171 | CMS |
| Indivior Inc. | $15.18 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144525712 | CMS |
| Indivior Inc. | $18.26 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144525714 | CMS |
| Lilly USA, LLC | $18.58 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135122841 | CMS |
| Lilly USA, LLC | $17.63 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135132329 | CMS |
| Neurocrine Biosciences, Inc. | $18.41 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150864259 | CMS |
| Neurocrine Biosciences, Inc. | $20.02 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150858709 | CMS |
| Orexo US, Inc. | $16.52 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136177224 | CMS |
| Orexo US, Inc. | $18.26 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136179800 | CMS |
| UCB, Inc. | $21.42 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143473042 | CMS |
| UCB, Inc. | $26.49 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143473049 | CMS |
| UCB, Inc. | $28.27 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143473057 | CMS |
| UCB, Inc. | $18.78 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143473063 | CMS |
| UCB, Inc. | $21.79 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143473069 | CMS |
| USWM, LLC | $22.07 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152822053 | CMS |
| USWM, LLC | $14.55 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152822107 | CMS |
| USWM, LLC | $13.33 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152822121 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.